Table: begin end state 1 36 cytoplasmic 37 54 transmembrane 55 73 non-cytoplasmic 74 97 transmembrane 98 106 cytoplasmic 107 125 transmembrane 126 130 non-cytoplasmic 131 149 transmembrane 150 173 cytoplasmic 174 195 transmembrane 196 200 non-cytoplasmic 201 221 transmembrane 222 271 cytoplasmic 272 295 transmembrane 296 308 non-cytoplasmic 309 333 transmembrane 334 344 cytoplasmic 345 363 transmembrane 364 368 non-cytoplasmic 369 390 transmembrane 391 401 cytoplasmic 402 425 transmembrane 426 430 non-cytoplasmic 431 452 transmembrane 453 480 cytoplasmic
Input: >PfGW456L13_5043 LTTIASKLAPAKHRYYPHKNNQWEYIYMQSTQKPTHVRYLILLMLFLVTTINYADRATIA IAGSSLQKDLGIDAVTLGYIFSAFGWAYVAGQIPGGWLLDRFGSKKIYALSIFTWSLFTV LQGFVGEFGMSTAVVALFMLRFLVGLAEAPSFPGNARIVAAWFPTAERGTASAIFNSAQY FATVLFAPLMGWIVYSFGWEHVFIVMGILGIIFSLVWLKVIYSPREHPRINDAEFKHISE NGGMVDMDQKGKKSDGPKWDYIRQLLTNRMMLGVYLGQYCINGITYFFLTWFPVYLVQER GMTILKAGFIASLPAICGFIGGVLGGVISDYLLRKGHSLTFARKAPIIAGLLVSSSIVAC NYVDVEWMVVGFMALAFFGKGVGALGWAVVSDTSPKQIAGLSGGLFNTFGNIASITTPIV IGYIISSTGSFKWALVFVGCNALVAVFSYLVIVGPIKRVVLKEPPANGTEAPGKLSQAHS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server